NCT05287854

Brief Summary

Virtual Reality (VR) is an interactive and immersive technology that allows you to evolve in a three-dimensional environment created by computer. It appeals to the senses of people by reproducing universes close to reality or imaginary. This process is currently the subject of numerous studies in the field of health because it is a non-invasive tool, a non-pharmacological alternative for the management of pain, anxiety and patient satisfaction. People with cancer can have a complex care pathway with psychological, anxiety-provoking and potentially painful repercussions. It is for these reasons that offering VR in the operating room for certain procedures under local anesthesia would improve the experience and comfort of care. BOREV study will assess the interest of VR on pain for procedures under local anesthesia in the operating room in the context of cancer care. The software used, called HypnoVR©, is a medical device, developed specifically for the management of anxiety and pain through hypnosis, sophrology and relaxation techniques. The main objective of this study is to compare the maximum pain felt with and without RV for different oncological surgical procedures performed under local anesthesia including anesthetic procedures and surgical procedures. The secondary objectives that will support this research are: the evaluation of the level of anxiety, the link with the pain component via the Analgesia Nociception Index (ANI), as well as the satisfaction of the patient and the operator. According to the results obtained, the VR device could lead to a change in practice in the management of patients and thus be offered on a larger scale within the framework of the management of pain and anxiety

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 18, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

June 16, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2023

Completed
Last Updated

October 7, 2025

Status Verified

October 1, 2025

Enrollment Period

1 year

First QC Date

January 18, 2022

Last Update Submit

October 1, 2025

Conditions

Keywords

Virtual realityPain controlAnxiety controlLocal anesthesiaSurgeryOperating roomAnalgesia Nociception Index (ANI)

Outcome Measures

Primary Outcomes (1)

  • Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of the maximum subjective pain induced by the surgical procedure

    Maximum subjective pain is measured by a numerical pain scale of 0 to 10. (0 : no pain ; 10 : maximum pain)

    Immediately after surgery

Secondary Outcomes (5)

  • Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of the objective pain induced by the surgical procedure in patients with Analgesia Nociception Index

    in preoperative ; during the surgical procedure ; immediate postoperative

  • Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of hemodynamic constants

    in preoperative ; during the surgical procedure ; immediate postoperative

  • Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of anxiety

    in preoperative ; immediate postoperative ; within 30 minutes after the surgery

  • Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of patient satisfaction

    immediate postoperative

  • Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of operator of the surgical procedure

    immediate postoperative

Study Arms (2)

Local anesthesia + Virtual Reality

EXPERIMENTAL

In addition to local standard anaesthesia, patients benefit from a virtual reality session during the operation using a virtual reality headset

Device: Virtual reality headset

Local anesthesia alone

NO INTERVENTION

Patients benefit only from a local anaesthesia is provided according to the standard procedure

Interventions

Once the patient is on the operating table, the nurse proposes the different possible VR scenarios and installs the RV headset and an audio headset.

Local anesthesia + Virtual Reality

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18 or more
  • Patient eligible for surgery under local anaesthesia in the operating room
  • Written informed consent obtained from the patient
  • Patient has valid health insurance

You may not qualify if:

  • Surgical procedure requiring complementary anaesthetic products such as intravenous sedation, nitrous oxide
  • Patient requiring an epidural, a paravertebral block
  • Patient with known allergy(ies) to local anaesthetics
  • Patient with schizophrenia, seizure disorder
  • For the investigation site with PhysioDoloris monitor (MDMS): Patient with contraindications to ANI monitoring:
  • Known heart rhythm disorder (complete arrhythmia by atrial fibrillation) Pacemaker Apnea
  • Administration of a sedative premedication in the 6 hours before the surgery
  • Visually or hearing impaired patient without a hearing aid
  • Patient deprived of liberty or under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

ICO

Angers, 49055, France

Location

ICO

Saint-Herblain, 44805, France

Location

MeSH Terms

Conditions

NeoplasmsAgnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2022

First Posted

March 18, 2022

Study Start

June 16, 2022

Primary Completion

June 27, 2023

Study Completion

June 27, 2023

Last Updated

October 7, 2025

Record last verified: 2025-10

Locations